Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The clinical trial page’s interface revision indicator was updated from v3.5.0 to v3.5.3, reflecting a behind-the-scenes version update rather than any change to study details.
    Difference
    0.0%
    Check dated 2026-04-25T06:15:22.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. The update does not modify study content or data on the page.
    Difference
    0.0%
    Check dated 2026-03-20T07:33:08.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.2 to v3.4.3. No changes to study data or visible content.
    Difference
    0.0%
    Check dated 2026-03-05T22:16:59.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the funding-status notice and the old Revision: v3.4.1 entry were removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:43:30.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A system-wide notice about potential data delays due to a lapse in government funding has been added, with links to cc.nih.gov and opm.gov. The page version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:33:15.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Show glossary option added and minor wording tweaks to QC-related labels and revision references. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:55:07.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.